Subscribe free

HPB & Spleen ·

Pancreatic Ductal Adenocarcinoma Resection: A 5.3-Year Journey to 95% Cure Probability

According to a multi-institutional analysis of 2554 patients, the probability of achieving the same life expectancy as the general population, with no tumor recurrence, after pancreatic surgery for pancreatic ductal adenocarcinoma (PDAC) was found to be 20.4%. Furthermore, the study revealed that the likelihood of cure reached 95% certainty after 5.3 years. Preoperative and postoperative models were developed, considering various factors such as tumor stage, size, chemotherapy response, and surgical variables, to predict patient outcomes. An online calculator was also provided for easily assessing cure probabilities.

Journal Article by Crippa S, Malleo G (…) Cucchetti A et 12 al. in Ann Surg

Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.

read the whole article in Ann Surg

open it in PubMed

Summaries are written to help you decide what to read. They do not replace the full paper.

Free · 5 minutes a day

Get every new paper in HPB & Spleen.

Plus the Daily Selection: the five most relevant papers of the day, each cut to its key points.

Specialty newsletters: every new paper in your field, as a list of titles linked to the source. Daily Selection: the five that matter, cut to their key points.

FreeNo spamOne-click unsubscribe

More in HPB & Spleen

The latest stitches

All papers in HPB & Spleen →